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INTRODUCTION:  Solid  pseudopapillary  neoplasms  are  rare  pancreatic  neoplasms  with  low  malignant
potential  and  favorable  prognosis  that  are  typically  seen  in  young  women.
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woman  who  was  treated  successfully  with  a  total  pancreatectomy.
CONCLUSION: To  the  best  of our knowledge,  this  is  the  ﬁrst  report  of  two  discrete  solid  pseudopapillary
neoplasms  in the  same  patient.
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. Introduction
Solid pseudopapillary neoplasms (SPNs) of the pancreas (also
nown as Hamoudi or Frantz tumors) are rare epithelial tumors of
he exocrine pancreas with low malignant potential that primar-
ly affect young women in the third and fourth decades of life.1,2
hey account for only 1% to 2% of all exocrine pancreatic tumors.3
PNs typically present with non-speciﬁc symptoms of abdominal
ain and/or a palpable abdominal mass.2 Characteristic features
n computed tomography (CT) are a well-circumscribed, heteroge-
eous cystic mass with areas of necrosis and internal hemorrhage.4
urgical resection can provide cure for localized disease and, hence,
hould be the treatment of choice.5 We  present a case of a 23-year
ld female with two large distinct SPNs who underwent a successful
otal pancreatectomy.
.  Presentation of case
A previously healthy 23-year old African American female,
2P2, presented with a sudden onset of severe epigastric pain with
adiation to her back. She had no associated changes in appetite or
aundice. She denied previous history of abdominal trauma or pan-
reatitis. Family history was negative for pancreatic diseases. The
xam was unremarkable, except for epigastric tenderness.
She  underwent an abdominal ultrasound and CT at an outside
ospital, which demonstrated two large masses in or abutting the
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Open access under CC BY-pancreas, one in the head and the other in the body/tail. Upon the
patient’s transfer to our institution, a pancreas protocol CT scan was
performed and showed two large, heterogeneous, multi-septated
cystic pancreatic masses (Fig. 1). The masses were predomi-
nantly cystic, with multiple internal septations and enhancing
solid components. There was  no evidence of pancreatic ductal
dilatation. The portal vein conﬂuence, splenic vein, and superior
mesenteric vein were compressed by the two adjacent pancre-
atic/peripancreatic masses without obstruction or invasion. The
celiac, superior mesenteric, hepatic, and splenic arteries were
patent.
The patient subsequently underwent upper endoscopic ultra-
sonography (EUS) for further characterization of the pancreatic
masses (Fig. 2). Two heterogeneous and mixed (solid and cystic)
masses were seen: one mass was  located in the head and mea-
sured 8 cm × 6 cm,  and the second separate mass was  located in the
body/tail and measured 6.6 cm × 5.8 cm.  The mass in the head of the
pancreas abutted the portal vein without invading it. The pancre-
atic duct was not dilated in the head, body or tail. EUS examination
was consistent with pancreatic SPN.
The patient underwent total pancreatectomy with splenec-
tomy. There was  no evidence of direct tumor invasion of adjacent
structures and vasculature, or tumor metastases. The overlying
pancreatic parenchyma appeared to be relatively normal with a
thin, translucent pancreatic capsule. There was  a bridge of rela-
tively normal, somewhat attenuated pancreas between the two
large masses, which were separate and not anatomically linked to
one another (Fig. 3). Diagnosis of SPN was conﬁrmed by intraoper-
ative frozen section.
On  gross pathology, the tumors were 9 cm and 7 cm in max-
imum diameter, respectively, and were conﬁned to the pancreas
(Fig. 4). The masses were grossly distinct and had multicystic and
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Fig. 2. Upper endoscopic ultrasound: (A) mixed mass in the head of the pancreas,
(B)  mixed mass in the body of the pancreas.ig. 1. (A) Coronal and (B) axial CT images showing two large complex multiseptated
ystic masses.
olid components. All 19 harvested lymph nodes were negative
or tumor. Immunohistochemical analysis was positive for beta-
atenin and CD10 and was negative for chromogranin, trypsin and
hymotrypsin. The ﬁnal histopathologic diagnosis was consistent
ith two large and separate benign pancreatic SPNs. Postopera-
ive course was unremarkable and patient was discharged home
n post-operative day 13 in good condition and on subcutaneous
nsulin therapy.
. Discussion
SPNs of the pancreas are typically solitary encapsulated masses
ith low malignant potential and favorable prognosis. More than
5% of patients are cured with complete surgical resection2. Factors
hat may  be associated with tumor recurrence include tumor size
reater than 5 cm,  venous invasion, nuclear grade, and prominent
ecrobiotic nests6,7; however, the predictive value of these features
ave not been consistent across all series.3,8,9
Fig. 3. Intraoperative photo of SPNs in head and body/tail of the pancreas with thick
ﬁbrotic capsule.
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ferent domains of the E-cadherin molecule. Histopathology 2008;52(Februaryig. 4. Gross appearance of the resected specimen: (A) the masses were grossly
istinct, (B) the masses had multicystic and solid components.
The genetic pathway of SPN formation is well known. SPNs
re characterized by the presence of activating -catenin gene
utations that interfere with phosphorylation of the protein
roduct.10,11 This results in the translocation of -catenin into
he nucleus, where it functions as a transcriptional regulator by
inding to targets including the growth regulatory genes cyclin
1 and c-myc.5 In addition, abnormal -catenin function may  also
xplain the poorly cohesive nature of SPN as it has been shown that
-catenin interacts with the cell adhesion molecule E-cadherin,
reventing the formation of normal cell-to-cell interactions.12
No prior reports have described two distinct pancreatic SPNs in
he same patient. The etiology behind the formation of two  lesions
f this size is unclear. One theory is that a primary tumor initially
ormed at one location and metastasized to a separate part of the
land to seed another location. This will be determined by further
enetic analyses of both tumors. Another theory is that the two
umors spontaneously and independently formed, perhaps due to
ame underlying predisposition in our patient.
Despite the extreme rarity of the patient’s presentation, the
rognosis is favorable. Complete excision of the tumor, and
etastatic disease if present, can result in excellent long term
urvival3,5,13. Perhaps of greater risk than that of recurrence or long
erm disease burden is that of iatrogenic diabetes mellitus as a con-
equence of total pancreatectomy. Recent studies,14–16 however,
ave shown that glycemic control after total pancreatectomy is
anagable and is associated with fewer glycemic complicationshan had been reported in the past.17–19 With adequate educa-
ion and support, our patient’s pronosis is good for recovery and
daptation to a new way of life.
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4. Conclusion
To the best of our knowledge, this is the ﬁrst report of two
discrete SPNs in the same patient. The patient underwent a suc-
cessful total pancreatectomy. Surgical resection can provide cure
for localized disease and, hence, should be the treatment of choice.
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